- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
R
RPRX
Royalty Pharma Plc
37.88
0.77+2.07%After Hours: 37.85 -0.03 -0.08%19:45 08/04 EDT
OPEN/PREV CLOSE37.22/37.11
TODAY RANGE37.22-37.91
VOL2.94M
MARKET CAP21.30B
52 WEEK RANGE23.73-37.91
AVG VOL (3M)4.44M
% TURNOVER0.52%
TURNOVER--
P/E (TTM)15.45
% RANGE1.86%
EPS(TTM)2.452
P/E(FORWARD)23.60
P/B3.208
BVPS11.81
DIVIDEND0.8800
P/S9.86
BETA--
DIV YIELD2.32%
FREE FLOAT MKT CAP14.48B
SHARES OUTSTANDING562.24M
NEXT EARNINGS08/06-08/11
FREE FLOAT382.26M
LOT SIZE1
EX-DATE08/15/2025
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Did Analyst Caution Before Earnings Change the Long-Term Thesis for Royalty Pharma (RPRX)?
Simply Wall St·6d ago
Does Board Refresh and Dividend Raise at Royalty Pharma (RPRX) Signal a Shift in Strategy?
Simply Wall St·6d ago
Will Royalty Pharma’s (RPRX) New Board Appointments Reshape Its Approach to Value Creation?
Seeking Alpha·07/26 17:00
Fidelity Dividend Growth Fund Q2 2025 Commentary
Simply Wall St·07/23 08:11
Will Dividend Approval and New Board Members Change Royalty Pharma's (RPRX) Narrative?
Dow Jones·07/22 13:07
Royalty Pharma Is Maintained at Buy by Citigroup
Dow Jones·07/22 13:07
Royalty Pharma Price Target Raised to $42.00/Share From $40.00 by Citigroup
Benzinga·07/22 12:57
Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $42
Reuters·07/22 10:05
ROYALTY PHARMA <RPRX.O>: CITIGROUP RAISES TARGET PRICE TO $42 FROM $40
TipRanks·07/22 10:00
Royalty Pharma price target raised to $42 from $40 at Citi
Reuters·07/22 07:27
U.S. RESEARCH ROUNDUP-Antero Resources, BKV, Cleveland-Cliffs
Seeking Alpha·07/18 12:19
Royalty Pharma declares $0.22 dividend
Reuters·07/18 12:15
Royalty Pharma plc Announces Third Quarter 2025 Dividend of $0.22 per Share
Dow Jones·07/18 12:15
Press Release: Royalty Pharma Declares Third Quarter 2025 Dividend
Same Industry
Name/Symbol
Change%
Price